Italy: Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik…
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine contracts, glass vial manufacturer…
Tagged with TEVA
The Long Read: Belgium – The Multifaceted
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical powerhouses of Germany and France,…
Hot Topics in Belgian Pharma
In 2020 PharmaBoardroom sat down with several key stakeholders in Belgian pharma to discuss company strategy, the Belgian healthcare landscape at…
Romania: Europe’s Most Challenging Market for Generics?
While the dismal regulatory environment in Romania has negatively affected the innovators with the uncertain and lengthy regulatory approval timelines…
Stana Moisescu – General Manager, Teva Romania
Stana Moisescu of Teva Pharmaceuticals Romania shares her insights on how to overcome unpredictability and inconsistency at the government level in…
Teun Grooters – CEO & Co-Founder, Arega Pharma,…
Teun Grooters, co-founder and CEO of Arega – the exclusive distributor of Teva generics in Belgium – tells the story of the newly founded…
Eric Deschepper – Managing Director, Teva Pharma Belgium
Teva Pharma Belgium's Eric Deschepper outlines how the global group's restructuring has impacted its Belgian operations, its realignment from a pure…
Jānis Meikšāns – General Manager, Teva Hungary
Jānis Meikšāns, newly appointed general manager of Teva Hungary, speaks about his first few months in the country. Meikšāns goes on to elaborate…
Christoph Stoller of Medicines for Europe on Tackling Drug…
Christoph Stoller, general manager for Austria and Germany at Teva was recently elected president of Medicines for Europe, the continent-wide…
Jean-Louis Anspach – General Manager, Teva France
Jean-Louis Anspach, general manager of Teva France, elaborates on the affiliate’s transitional restructuring period as they make a turnaround effort…
Top 10 Orphan Drugs in the USA
The Top 10 bestselling orphan drugs in the USA in 2017. Celgene's Revlimid (generic name lenolidamide) leads the way with sales of USD 5.4 billion,…
Turkish Pharma: Crisis-Proof?
Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being…
